Document 0184
 DOCN  M9590184
 TI    The Australian Study of HIV and Injecting Drug Use (ASHIDU): research in
       progress.
 DT    9509
 AU    Loxley W; Carruthers S; Wodak A; Crofts N; Dolan K; Gaughwin M; Kaldor
       J; National Centre for Research into the Prevention of Drug Abuse,;
       Perth, Western Australia.
 SO    Annu Conf Australas Soc HIV Med. 1994 Nov 3-6;6:95 (unnumbered
       abstract). Unique Identifier : AIDSLINE ASHM6/95291915
 AB    ASHIDU, a multi-centre CARG study, is a cross-sectional survey which
       aims to provide data to facilitate the maximum achievable reduction of
       HIV transmission among and from injecting drug users in Australia. Nine
       hundred current injecting drug users, from treatment and non-treatment
       samples, will be surveyed in Adelaide, Melbourne Perth and Sydney in
       1994. Blood samples will be taken from all willing subjects to be
       anonymously tested for HIV, HBV and HCV. This paper will trace the
       evolution of ASHIDU, including similarities with and differences from
       previous Australian studies. Sampling strategies rely on networking
       snowballing and advertising, using treatment centres, Needle Exchange
       Programs and other agencies as start points. Eligibility criteria and
       behavioural measures differ from previous Australian studies. The
       objectives for ASHIDU were developed in collaboration with the
       Commonwealth Department of Health. Base line data will be collected on
       overdose, IDU organisations and barriers to treatment seeking as well as
       knowledge, attitudes and behaviour relevant to the transmission of major
       blood borne viruses. The ASHIDU questionnaire was developed from the
       revised ANAIDUS questionnaire (ANAIDUS-Q). Comparability of data between
       cities and the reproducibility of data across time are important
       considerations Centralised training of interviewers and standardised
       record keeping are among quality control strategies. Rapid dissemination
       of policy relevant analysis is a major commitment.
 DE    Australia  Health Policy  Hepatitis C/PREVENTION & CONTROL/TRANSMISSION
       Human  HIV Infections/*PREVENTION & CONTROL/TRANSMISSION  Risk Factors
       Substance Abuse, Intravenous/COMPLICATIONS/*REHABILITATION  MEETING
       ABSTRACT

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).